← FDA DRUG APPROVALS

FDA ANDA · ANDA204593

ADAPALENE

Sponsor: WAYLIS THERAP

APPLICATION
ANDA204593
TYPE
ANDA
ORIGINAL APPROVAL
2016-01-05
LATEST ACTION
2017-07-11
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

ADAPALENEPrescription
ADAPALENE 0.1% · SOLUTION · TOPICAL

Approval history

2017-07-11Labeling · Supplement 1 · standardAP
2016-01-05UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →